Build Strong, Defensible, Commercial Evidence That Drives Market Success

From rigorous due diligence and gap analysis to full clinical development strategy and publication planning - I help raw material and nutraceutical companies generate high-value scientific evidence while protecting and maximising research budgets.

Why Evidence Strategy Matters

Most ingredient companies waste hundreds of thousands of dollars on poorly targeted or weakly designed studies. A strategic, integrated approach to evidence development turns research from a cost centre into a powerful commercial asset.

I provide end-to-end scientific leadership across the full evidence lifecycle.

CORE SERVICES

  • Before spending a dollar on new trials.

    • Comprehensive review of published & unpublished studies, patents, competitor evidence, and regulatory landscape

    • Evidence strength assessment + gap identification

      Deliverables: Scientific reports, dossiers, evidence gap analysis, SWOT, clinical development roadmap

  • The highest-value service. Develop multi-year evidence generation plans that align regulatory, marketing, and commercial goals. Key questions addressed: target indications, populations, endpoints, journals, countries, etc.

  • Design pilot, proof-of-concept, mechanistic, dose-finding, and pivotal studies. Expert support on endpoints, biomarkers, inclusion/exclusion criteria, statistical planning, sample size, budget...

  • Design studies so that even if the primary endpoint fails, valuable secondary, mechanistic, biomarker, and subgroup data remain.

    Protect your research investment and existing products

  • Identify high-performing universities, CROs, principal investigators, and KOLs based on capability, track record, and cost-effectiveness.

  • Prepare/review protocols, SAPs, investigator brochures. Provide ongoing scientific monitoring during trial conduct.

  • Review and strengthen CSRs, statistical interpretations, and scientific conclusions for maximum regulatory, publication, and commercial value.

  • Coordinated publication plans, manuscript development, conference strategy, and reviewer response support.

    Internal and External education strategy and material development

  • Evaluate defensible claims, create comprehensive dossiers and Claim Evidence File for TGA, FSANZ, FDA, EFSA, and other markets.

  • Translate science into sales tools, monographs, white papers, distributor training, advisory boards, and symposia.

    • Competitive Intelligence

    • New Indication Discovery

    • New Technology Evaluation

    • Portfolio Research Management

    • M&A Scientific Due Diligence

    • Long-term Scientific Advisory Board Role

Benefits

  • Avoid costly unnecessary trials

  • Maximise ROI on research dollar

  • Generate defensible regulatory and marketing claims

  • Turn potential “failures” into valuable assets

  • Build a strong, coherent evidence package over time

  • Strengthen competitive positioning

  • Support successful market entry and B2B sales